Moderately Hypofractionated Adaptive Radiotherapy for Cervical Cancer

Status Recruiting

Clinical Trial Summary

External radiation given in 25 fractions or so together with weekly chemotherapy and followed by 5 or 6 fractions of brachytherapy is the standard of care for patients with locally advanced cervical cancer. We hope to develop external moderately hypofractionated radiotherapy of cervical cancer based on adaptive radiotherapy.The objective of this study is to evaluate the efficacy and treatment-related toxicity of moderately hypofractionated adaptive radiotherapy in the treatment of cervical cancer.

Clinical Trial Description

This is an investigator-initiated efficacious, single-center, open-label clinical trial study. This study hypothesizes that the use of external moderately hypofractionated radiotherapy of cervical cancer based on adaptive radiotherapy. A dose of 43.35Gy in 17 fractions is delivered to clinical target volume (CTV). Patients receive cisplatin based concurrent chemotherapy. The primary endpoint is acute toxicity. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05994300
Study type	Interventional
Source	Peking Union Medical College Hospital
Contact	Fuquan Zhang, MD
Phone	86-10-6915-5485
Email	Zhangfq@pumch.cn
Status	Recruiting
Phase	N/A
Start date	September 19, 2023
Completion date	December 31, 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05453318` - Efficacy and Acceptability of Thermal Ablation in the Treatment of Cervical Neoplasia	N/A
Completed	`NCT01524003` - Chinese Cancer Prevention Study(CHICAPS)	N/A
Completed	`NCT01338051` - The Development of a "Mother/Child, Screen, Treat and Vaccinate Program" in Manchay and Iquitos, Peru	Phase 1
Active, not recruiting	`NCT04870177` - Study of AK112 in the Treatment of Advanced Gynecological Tumors	Phase 2
Recruiting	`NCT05870787` - iMproving thE DIagnostics And Treatment Of ceRvical Precancer
Recruiting	`NCT03055130` - HPV Infection and Cervical Neoplasm in Women With Inflammatory Bowel Disease: a Cross-sectional Study	N/A
Recruiting	`NCT04403867` - The Role of Micrometastasis and Isolated Tumor Cells (ITCs) in Endometrial and Cervical Cancer. A Multicenter Study.
Completed	`NCT03239223` - Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection	Phase 1
Recruiting	`NCT04249856` - Colposcopy and Dynamic Spectral Imaging (DSI)
Completed	`NCT03697226` - Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection.	Phase 1
Completed	`NCT03895905` - Comparison of Cervical Pathologies in the Presence of High Risk Hpv Positivity
Active, not recruiting	`NCT03000192` - HORIZONS: Understanding the Impact of Cancer Diagnosis and Treatment on Everyday Life
Completed	`NCT03418480` - HARE-40: HPV Anti-CD40 RNA vaccinE	Phase 1/Phase 2